Some groups are also evaluating alternative antigen candidates, such as NA, NP and M2, which are well conserved in multiple influenza strains and generate protective immunity through non-neutralizing antibodies helping to control the infection; hence, a multi-component vaccine not limited to HA antigen can be also considered. This evidence concerns the gene XK and influenza.